|
|
40
|
B5319
|
CASPOGIN 50MG INJ (CIP/AHI) CASPOFUNGIN
|
CASPOFUNGIN
|
CASPOGIN
|
10ML VIAL
|
BQ
|
335.28
|
335.28
|
INJECTION
|
0
|
VIAL
|
CIP
|
CIPLA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
081416
|
ECHINOCANDINS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
40
|
B5831
|
APO-NABILONE 1MG CAP (APO/COL)
|
NABILONE
|
APO-NABILONE
|
50'S
|
A
|
66.00
|
1.32
|
CAPSULE
|
30
|
CAP
|
APO
|
APOTEX INC.
|
COL
|
COLLINS LTD
|
|
9200
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
|
|
|
40
|
B5832
|
APO-NABILONE 0.25MG CAP (APO/COL)
|
NABILONE
|
APO-NABILONE
|
50'S
|
A
|
23.05
|
0.46
|
CAPSULE
|
30
|
CAP
|
APO
|
APOTEX INC.
|
COL
|
COLLINS LTD
|
|
9200
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
|
|
|
41
|
B5911
|
AMLOTENSIVE CT 5MG|25MG TAB (CAR/COL) AMLODIPINE|CHLORTHALIDONE
|
AMLODIPINE|CHLORTHALIDONE
|
AMLOTENSIVE CT
|
210'S
|
A
|
26.26
|
0.125
|
TAB
|
60
|
TAB
|
CAR
|
CARLISLE LABORATORIES LTD
|
COL
|
COLLINS LTD
|
B
|
242892
|
CCBs, MISCELLANEOUS
|
|
|
|
ORAL
|
6
|
CARDIOVASCULAR DRUGS
|
|
|
|
40
|
B5911
|
AMLOTENSIVE CT 5MG | 25MG TAB (CAR/COL) AMLODIPINE | CHLORTHALIDONE
|
AMLODIPINE|CHLORTHALIDONE
|
AMLOTENSIVE CT
|
210'S
|
A
|
26.26
|
0.13
|
TABLET
|
60
|
TAB
|
CAR
|
CARLISLE LABORATORIES LTD
|
COL
|
COLLINS LTD
|
B
|
240892
|
HYPOTENSIVE AGENTS, MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CARDIOVASCULAR DRUGS
|
|
|
|
41
|
B5921
|
AMLOTENSIVE CT 5MG|50MG TAB (CAR/COL) AMLODIPINE|CHLORTHALIDONE
|
AMLODIPINE|CHLORTHALIDONE
|
AMLOTENSIVE CT
|
210'S
|
A
|
35.9091
|
0.171
|
TAB
|
30
|
TAB
|
CAR
|
CARLISLE LABORATORIES LTD
|
COL
|
COLLINS LTD
|
B
|
9244
|
IMMUNOSUPPRESSIVE AGENTS
|
|
|
|
ORAL
|
6
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
|
|
|
40
|
B5921
|
AMLOTENSIVE CT 5MG | 50MG TAB (CAR/COL) AMLODIPINE | CHLORTHALIDONE
|
AMLODIPINE|CHLORTHALIDONE
|
AMLOTENSIVE CT
|
210'S
|
A
|
35.90
|
0.17
|
TABLET
|
30
|
TAB
|
CAR
|
CARLISLE LABORATORIES LTD
|
COL
|
COLLINS LTD
|
B
|
240892
|
HYPOTENSIVE AGENTS, MISCELLANEOUS
|
2022-07-11
|
2024-03-31
|
Add to Contract as Cat A
|
Oral
|
6
|
CARDIOVASCULAR DRUGS
|
2022-07-11
|
|
|
41
|
B5931
|
AMLOTENSIVE CT 10MG|25MG TAB (CAR/COL) AMLODIPINE|CHLORTHALIDONE
|
AMLODIPINE|CHLORTHALIDONE
|
AMLOTENSIVE CT
|
210'S
|
A
|
26.259
|
0.125
|
TAB
|
30
|
TAB
|
CAR
|
CARLISLE LABORATORIES LTD
|
COL
|
COLLINS LTD
|
B
|
9244
|
IMMUNOSUPPRESSIVE AGENTS
|
|
|
|
ORAL
|
6
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
|
|
|
40
|
B5931
|
AMLOTENSIVE CT 10MG | 25MG TAB (CAR/COL) AMLODIPINE | CHLORTHALIDONE
|
AMLODIPINE|CHLORTHALIDONE
|
AMLOTENSIVE CT
|
210'S
|
A
|
26.26
|
0.13
|
TABLET
|
30
|
TAB
|
CAR
|
CARLISLE LABORATORIES LTD
|
COL
|
COLLINS LTD
|
B
|
240892
|
HYPOTENSIVE AGENTS, MISCELLANEOUS
|
2022-07-11
|
2024-03-31
|
Add to Contract as Cat A
|
oral
|
6
|
CARDIOVASCULAR DRUGS
|
2022-07-11
|
|
|
41
|
B5941
|
AMLOTENSIVE CT 10MG|50MG TAB (CAR/COL) AMLODIPINE|CHLORTHALIDONE
|
AMLODIPINE|CHLORTHALIDONE
|
AMLOTENSIVE CT
|
210'S
|
A
|
35.9091
|
0.171
|
TAB
|
30
|
TAB
|
CAR
|
CARLISLE LABORATORIES LTD
|
COL
|
COLLINS LTD
|
B
|
9244
|
IMMUNOSUPPRESSIVE AGENTS
|
|
|
|
ORAL
|
6
|
UNCLASSIFIED THERAPEUTIC AGENTS
|
|
|
|
40
|
B5941
|
AMLOTENSIVE CT 10MG | 50MG TAB (CAR/COL) AMLODIPINE | CHLORTHALIDONE
|
AMLODIPINE|CHLORTHALIDONE
|
AMLOTENSIVE CT
|
210'S
|
A
|
35.90
|
0.17
|
TABLET
|
30
|
TAB
|
CAR
|
CARLISLE LABORATORIES LTD
|
COL
|
COLLINS LTD
|
B
|
240892
|
HYPOTENSIVE AGENTS, MISCELLANEOUS
|
2022-07-11
|
2022-03-31
|
Add to Contract as Cat A
|
oral
|
6
|
CARDIOVASCULAR DRUGS
|
2022-07-11
|
|
|
41
|
B6211
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
41
|
B6211
|
GLYXAMBI 25MG|5MG TAB (BOE/STO) EMPAGLIFLOZIN|LINAGLIPTIN
|
EMPAGLIFLOZIN|LINAGLIPTIN
|
GLYXAMBI
|
30'S
|
C
|
118.79
|
3.9597
|
TAB
|
0
|
TAB
|
BOE
|
BOEHRINGER INGELHEIM
|
STO
|
BRYDEN STOKES LTD
|
|
682005
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
|
|
Add to Contract as Cat C
|
ORAL
|
0
|
HORMONES AND SYNTHETIC SUBSTITUTES
|
|
|
|
0
|
Brand C
|
Brand Name
|
Active Ingredient
|
Trade Name
|
Package Si
|
Fo
|
Pkg Price
|
Unit Pric
|
Unit Descrip
|
|
Pack
|
Man
|
Manufacturer Name
|
Age
|
Agent Name
|
B
|
Therapeu
|
Therapeutic Desc
|
|
|
Status Description
|
Default Route
|
0
|
Therapeutic Head
|
|
|
|
0
|
Brand C
|
Brand Name
|
Active Ingredient
|
Trade Name
|
Package Si
|
Fo
|
Pkg Price
|
Unit Pric
|
Unit Descrip
|
0
|
Pack
|
Man
|
Manufacturer Name
|
Age
|
Agent Name
|
B
|
Therapeu
|
Therapeutic Desc
|
|
|
Status Description
|
Default Route
|
0
|
Therapeutic Head
|
|